Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yasufumi Saitoh"'
Autor:
Shoichiro Mukai, MD, PhD, Yasufumi Saitoh, Tomoaki Bekki, Toshiyuki Moriuchi, Yosuke Namba, Sho Okimoto, Koichi Oishi, Toshikatsu Fukuda, Toshihiro Nishida, Hiroyuki Egi, Hideki Ohdan
Publikováno v:
Radiology Case Reports, Vol 16, Iss 5, Pp 1089-1094 (2021)
The anomalies of the middle colic artery have rarely been reported and reviewed in literature. However, in case such anomalies are observed in clinical practice, surgery must still be performed safely. This report presents the case of a 78-years-old
Externí odkaz:
https://doaj.org/article/41b26942577b4bf3afee2d2916bad797
Autor:
Hisaaki Yoshinaka, Manabu Shimomura, Hiroyuki Egi, Wataru Shimizu, Tomohiro Adachi, Satoshi Ikeda, Masahiro Nakahara, Yasufumi Saitoh, Kazuhiro Toyota, Masanori Yoshimitsu, Shintaro Akabane, Takuya Yano, Minoru Hattori, Hideki Ohdan
Publikováno v:
British Journal of Surgery; Dec2023, Vol. 110 Issue 12, p1769-1773, 5p
Autor:
Manabu Shimomura, Satoshi Ikeda, Masahiro Nakahara, Tomohiro Adachi, Yasufumi Saitoh, Yosuke Shimizu, Kazuhiro Toyota, Yasuyo Ishizaki, Masanori Yoshimitsu, Yuji Takakura, Wataru Shimizu, Daisuke Sumitani, Shinya Kodama, Masahiko Fujimori, Mamoru Oeda, Hironori Kobayashi, Hideki Ohdan
Publikováno v:
Journal of Clinical Oncology. 41:102-102
102 Background: There was no consensus about the safety and effectiveness of adjuvant chemotherapy for patients with stage III colorectal cancer (CRC) aged ≥80 years who underwent curative resection. We conducted a prospective cohort study of patie
Autor:
Masashi Miguchi, Satoshi Ikeda, Manabu Shimomura, Masahiro Nakahara, Tomohiro Adachi, Yasuyo Ishizaki, Yasufumi Saitoh, Kazuhiro Toyota, Daisuke Sumitani, Yosuke Shimizu, Yuji Takakura, Wataru Shimizu, Masanori Yoshimitsu, Shinya Kodama, Masahiko Fujimori, Mamoru Oeda, Hironori Kobayashi, Hideki Ohdan
Publikováno v:
Journal of Clinical Oncology. 41:101-101
101 Background: There is no consensus on the safety and effectiveness of adjuvant chemotherapy for patients with stage III colorectal cancer (CRC) aged ≥80 years who underwent curative resection. We conducted a prospective phase II feasibility stud